These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 17530659

  • 1. Identification of transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon by nailfold videocapillaroscopy: comment on the article by Hirschl et al.
    Cutolo M, Pizzorni C, Sulli A.
    Arthritis Rheum; 2007 Jun; 56(6):2102-3; author reply 2103-4. PubMed ID: 17530659
    [No Abstract] [Full Text] [Related]

  • 2. Nailfold capillaroscopic findings in primary Sjögren's syndrome with and without Raynaud's phenomenon and/or positive anti-SSA/Ro and anti-SSB/La antibodies.
    Corominas H, Ortiz-Santamaría V, Castellví I, Moreno M, Morlà R, Clavaguera T, Erra A, Martínez-Pardo S, Ordóñez S, Santo P, Reyner P, González MJ, Codina O, Gelman MS, Juanola-Roura X, Olivé A, Torrente-Segarra V, CapiCAT group.
    Rheumatol Int; 2016 Mar; 36(3):365-9. PubMed ID: 26597492
    [Abstract] [Full Text] [Related]

  • 3. [Nailfold capillaroscopy in children and adolescents with rheumatic diseases].
    Petry DG, Terreri MT, Len CA, Hilário MO.
    Acta Reumatol Port; 2008 Mar; 33(4):395-400. PubMed ID: 19107084
    [Abstract] [Full Text] [Related]

  • 4. Capillaroscopy.
    Cutolo M, Pizzorni C, Secchi ME, Sulli A.
    Best Pract Res Clin Rheumatol; 2008 Dec; 22(6):1093-108. PubMed ID: 19041079
    [Abstract] [Full Text] [Related]

  • 5. [Minimal work-up for Raynaud syndrome: a consensus report. Microcirculation Working Group of the French Vascular Medicine Society].
    Pistorius MA, Carpentier PH, le groupe de travail « Microcirculation » de la Société française de médecine vasculaire.
    J Mal Vasc; 2012 Jul; 37(4):207-12. PubMed ID: 22749761
    [Abstract] [Full Text] [Related]

  • 6. Raynaud's phenomenon and the role of capillaroscopy.
    Cutolo M, Grassi W, Matucci Cerinic M.
    Arthritis Rheum; 2003 Nov; 48(11):3023-30. PubMed ID: 14613262
    [No Abstract] [Full Text] [Related]

  • 7. Computerized nailfold video capillaroscopy--a new tool for assessment of Raynaud's phenomenon.
    Anderson ME, Allen PD, Moore T, Hillier V, Taylor CJ, Herrick AL.
    J Rheumatol; 2005 May; 32(5):841-8. PubMed ID: 15868619
    [Abstract] [Full Text] [Related]

  • 8. Improving outcome prediction of systemic sclerosis from isolated Raynaud's phenomenon: role of autoantibodies and nail-fold capillaroscopy.
    Ingegnoli F, Boracchi P, Gualtierotti R, Biganzoli EM, Zeni S, Lubatti C, Fantini F.
    Rheumatology (Oxford); 2010 Apr; 49(4):797-805. PubMed ID: 20100796
    [Abstract] [Full Text] [Related]

  • 9. [Raynaud's phenomenon; diagnosis and treatment].
    Hofstee HM, Voskuyl AE, Serné EH, Smulders YM.
    Ned Tijdschr Geneeskd; 2009 Apr; 153():B216. PubMed ID: 19785782
    [Abstract] [Full Text] [Related]

  • 10. Raynaud's phenomenon.
    Lally EV.
    Curr Opin Rheumatol; 1992 Dec; 4(6):825-36. PubMed ID: 1457277
    [Abstract] [Full Text] [Related]

  • 11. Associations of nailfold capillary abnormalities and immunological markers in early Raynaud's phenomenon.
    Schlager O, Kiener HP, Stein L, Hofkirchner J, Zehetmayer S, Ristl R, Perkmann T, Smolen JS, Koppensteiner R, Gschwandtner ME.
    Scand J Rheumatol; 2014 Dec; 43(3):226-33. PubMed ID: 24517537
    [Abstract] [Full Text] [Related]

  • 12. Laser Doppler perfusion imaging is useful in the study of Raynaud's phenomenon and improves the capillaroscopic diagnosis.
    Rosato E, Borghese F, Pisarri S, Salsano F.
    J Rheumatol; 2009 Oct; 36(10):2257-63. PubMed ID: 19684154
    [Abstract] [Full Text] [Related]

  • 13. Reliability of widefield nailfold capillaroscopy and video capillaroscopy in the assessment of patients with Raynaud’s phenomenon.
    Sekiyama JY, Camargo CZ, Eduardo L, Andrade C, Kayser C.
    Arthritis Care Res (Hoboken); 2013 Nov; 65(11):1853-61. PubMed ID: 23754794
    [Abstract] [Full Text] [Related]

  • 14. [Raynaud's phenomenon. Practical considerations on the forms secondary to immunomediated systemic diseases].
    Marcolongo R, Corà F, Laveder F, Cavallo M, Busato A, Rigoli AM.
    Minerva Med; 1997 Nov; 88(7-8):307-10. PubMed ID: 9304074
    [Abstract] [Full Text] [Related]

  • 15. [Capillaroscopy and Raynaud's phenomenon].
    Carpentier P, Franco A.
    J Mal Vasc; 1984 Nov; 9(1):23-8. PubMed ID: 6707531
    [Abstract] [Full Text] [Related]

  • 16. The role of nail-videocapillaroscopy in early diagnosis of scleroderma.
    Rossi D, Russo A, Manna E, Binello G, Baldovino S, Sciascia S, Roccatello D.
    Autoimmun Rev; 2013 Jun; 12(8):821-5. PubMed ID: 23219768
    [Abstract] [Full Text] [Related]

  • 17. [Minimal work-up for Raynaud syndrome: a consensus report. Microcirculation working group of the Société française de médecine vasculaire].
    Pistorius MA, Carpentier PH, le groupe de travail « Microcirculation » de la Société française de médecine vasculaire.
    Ann Dermatol Venereol; 2013 Jun; 140(8-9):549-54. PubMed ID: 24034643
    [Abstract] [Full Text] [Related]

  • 18. [Prognostic factors in Raynaud's phenomenon: usefulness of antinuclear antibodies and of periungual capillaroscopy].
    Passiu G, Sebastiani GD, Galeazzi M, Tuveri MA, Nicosia PM, Boirivant R.
    Medicina (Firenze); 1990 Jun; 10(4):405-7. PubMed ID: 2099984
    [Abstract] [Full Text] [Related]

  • 19. Nailfold capillaroscopy in systemic sclerosis: is there any difference between videocapillaroscopy and dermatoscopy?
    Dogan S, Akdogan A, Atakan N.
    Skin Res Technol; 2013 Nov; 19(4):446-9. PubMed ID: 23521585
    [Abstract] [Full Text] [Related]

  • 20. Re-evaluation of nailfold capillaroscopy in discriminating primary from secondary Raynaud's phenomenon and in predicting systemic sclerosis: a randomised observational prospective cohort study.
    Amaral MC, Paula FS, Caetano J, Ames PR, Alves JD.
    Expert Rev Clin Immunol; 2024 Jun; 20(6):665-672. PubMed ID: 38465507
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.